CALONGHI, NATALIA
 Distribuzione geografica
Continente #
NA - Nord America 7.575
AS - Asia 6.150
EU - Europa 6.145
AF - Africa 497
SA - Sud America 300
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.685
Nazione #
US - Stati Uniti d'America 7.488
CN - Cina 2.026
SG - Singapore 1.923
IT - Italia 1.398
GB - Regno Unito 1.375
VN - Vietnam 972
DE - Germania 764
SE - Svezia 664
IN - India 384
HK - Hong Kong 378
UA - Ucraina 369
RU - Federazione Russa 310
NL - Olanda 285
FR - Francia 263
BR - Brasile 211
IE - Irlanda 207
KR - Corea 178
CI - Costa d'Avorio 129
ZA - Sudafrica 108
SC - Seychelles 101
TG - Togo 97
JP - Giappone 85
BG - Bulgaria 79
FI - Finlandia 77
EE - Estonia 75
CH - Svizzera 59
CA - Canada 53
BE - Belgio 46
AR - Argentina 43
NG - Nigeria 38
PL - Polonia 37
JO - Giordania 35
ID - Indonesia 34
IR - Iran 32
GR - Grecia 23
AT - Austria 22
HR - Croazia 21
MX - Messico 20
TR - Turchia 18
CL - Cile 15
PK - Pakistan 15
CZ - Repubblica Ceca 13
AU - Australia 12
EC - Ecuador 12
LT - Lituania 12
RO - Romania 11
BD - Bangladesh 10
ES - Italia 10
IQ - Iraq 9
LB - Libano 9
AE - Emirati Arabi Uniti 8
TW - Taiwan 8
EG - Egitto 7
MY - Malesia 7
MA - Marocco 6
PT - Portogallo 6
CO - Colombia 5
DK - Danimarca 5
PE - Perù 5
PY - Paraguay 4
VE - Venezuela 4
AM - Armenia 3
BZ - Belize 3
EU - Europa 3
SN - Senegal 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CU - Cuba 2
DO - Repubblica Dominicana 2
GI - Gibilterra 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MK - Macedonia 2
PA - Panama 2
SI - Slovenia 2
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
GL - Groenlandia 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
Totale 20.684
Città #
Singapore 1.310
Ashburn 1.287
Southend 1.162
Chandler 658
Bologna 466
Fairfield 440
Houston 421
Santa Clara 399
Hong Kong 372
Hefei 364
Dong Ket 312
Ann Arbor 306
Princeton 263
Jacksonville 253
Wilmington 230
Beijing 224
Dublin 206
Boardman 205
Seattle 204
Woodbridge 200
Cambridge 170
Seoul 147
Abidjan 129
Ho Chi Minh City 128
Nanjing 128
Dallas 121
Westminster 119
Los Angeles 115
New York 107
Berlin 106
Padova 105
Lomé 97
Frankfurt am Main 88
Milan 87
Hanoi 85
Medford 82
Sofia 77
Tokyo 77
Jinan 75
Buffalo 71
Saint Petersburg 67
Shenyang 58
Changsha 56
Guangzhou 56
Turin 53
Nanchang 50
Munich 49
Helsinki 48
Brussels 46
Falls Church 44
Shanghai 43
Mülheim 42
Bengaluru 41
Hebei 40
Bern 38
Abeokuta 37
Dearborn 37
Pune 37
The Dalles 37
Amman 35
Redmond 34
Redondo Beach 34
San Diego 34
Tianjin 32
Toronto 31
Verona 31
Des Moines 29
Mahé 28
Council Bluffs 26
London 26
Hyderabad 25
Jakarta 25
Jiaxing 25
Bremen 24
São Paulo 23
Redwood City 22
Amsterdam 21
Chicago 21
Falkenstein 21
Haikou 21
Zhengzhou 21
Rome 20
Warsaw 20
Wuhan 20
Florence 19
Nuremberg 19
Hangzhou 18
Lappeenranta 18
Norwalk 17
Forlì 16
Fremont 16
Phoenix 16
Ningbo 15
Orem 15
Taiyuan 15
Brooklyn 14
Denver 14
Olalla 14
Vienna 14
Washington 14
Totale 13.178
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 504
EFFECTS OF 9-HYDROXYSTEARIC ACID ON CELL PROLIFERATION AND CYTOSKELETON ORGANIZATION IN HCT116 COLON CARCINOMA CELLS. 338
Coenzyme Q biosynthesis inhibition induces HIF-1α stabilization and metabolic switch toward glycolysis 270
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 253
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 248
Isolation of vaginal lactobacilli and characterization of anti-candida activity 243
A peptidic hydrogel that may behave as a "trojan Horse" 229
Effects of Regioisomerism on the Antiproliferative Activity of Hydroxystearic Acids on Human Cancer Cell Lines 219
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 207
Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells 207
Antitumor Activity of New Substituted 3-(5-Imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-Imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: Selectivity Against Colon Tumor Cells and Effect on Cell Cycle-Related Events. 203
A new EGFR inhibitor induces apoptosis in colon cancer cells. 203
Unprecedented Behavior of (9 R)-9-Hydroxystearic Acid-Loaded Keratin Nanoparticles on Cancer Cell Cycle 201
9-HYDROXYSTEARIC ACID INTERFERES WITH EGF SIGNALLING IN A HUMAN COLON ADENOCARCINOMA 200
ANTITUMOR ACTIVITY OF INDOLE-DERIVATIVES IN THE HUMAN OVARIAN CANCER CELL LINE IGROV-1 196
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 193
SUBSTITUTED E-3-(3-INDOLYLMETHYLENE)1,3-DIHYDROINDOL-2-ONES WITH ANTITUMOR ACTIVITY. IN-DEPTH STUDY OF THE EFFECT ON GROWTH OF BREAST CANCER CELLS. 190
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 186
Substituted E-3-(3-Indolylmethylene)-1,3-dihydroindol-2-ones with Antitumor Activity. In Depth Study of the Effect on Growth of Breast Cancer Cells 182
EFFECT OF 9-HYDROXY-STEARIC ACID ON GLUCOSE METABOLISM IN A HUMAN COLON CANCER CELL LINE 181
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 180
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 180
(R)-9-HSA HAS A MORE REMARKABLE ANTIPROLIFERATIVE EFFECT COMPARE TO (S)-9-HSA. 180
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 180
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 180
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 180
Natural Astaxanthin Is a Green Antioxidant Able to Counteract Lipid Peroxidation and Ferroptotic Cell Death 179
ANTITUMOR ACTIVITY OF NEW SUBSTITUTED 3-(5- IMIDAZO[2,1-b]THIAZOLYLMETHYLENE)-2-INDOLINONES 179
Myrcene: A Natural Compound Showing Anticancer Activity in HeLa Cells 176
New Antitumor Imidazo[2,1-b]thiazole Guanylhydrazones and Analogues 176
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 176
9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma 173
Purification of active recombinant human histone deacetylase 1 (HDAC1) overexpressed in Escherichia coli 171
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 171
Histone deacetylase 1: a target of 9-hydroxystearic acid in the inhbition of cell growth in human colon cancer 170
N-methylformamide and 9-hydroxystearic acid: two anti-proliferative and differentiating agents with different modes of action in colon cancer cells 168
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 168
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 168
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis. 167
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 167
9-hydroxystearic acid is a histone deacetylase inhibitor 166
The role of caspase-9, bax, and p53 in the apoptotic response triggered by 9-hydroxystearic acid 165
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 165
Synthesis and Antiproliferative Activity against Cancer Cells of Indole-Aryl-Amide Derivatives 163
Synthesis of 9-hydroxystearic acid derivatives and their antiproliferative activity on HT 29 cancer cells 162
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 161
Substrate Type and Concentration Differently Affect Colon Cancer Cells Ultrastructural Morphology, EMT Markers, and Matrix Degrading Enzymes 159
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 158
Chitosan nanoparticles for curcumin delivery: development, characterization and in-vitro studies on cancer cells 158
Design of α/β-hybrid peptide ligands of α4β1 integrin equipped with a linkable side chain for chemoselective biofunctionalization of microstructured materials 158
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 156
The EGF- induced cell proliferation and migration in HT29 is inhibited by 9-hydroxystearic acid 151
Unprecedented behavior of (9R)-9-hydroxystearic acid loaded keratin nanoparticles on cancer cell cycle 150
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 149
4-hydroxy-2,3 trans-nonenal nuclear concentration inversely correlates with the growth rate of T leukemia cells. 148
Redox Signaling via Lipid Peroxidation Regulates Retinal Progenitor Cell Differentiation. 147
Root Extracts of Two Cultivars of Paeonia Species: Lipid Composition and Biological Effects on Different Cell Lines: Preliminary Results 147
Synthesis of novel structural hybrids between aza-heterocycles and azelaic acid moiety with a specific activity on osteosarcoma cells 146
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 144
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene 144
NUCLEAR REDISTRIBUTION OF EXOGENOUS ADMINISTERED 9- AND 10-HSA, ANALYZED BY MASS SPECTROMETRY 141
HISTONE DEACETYLASE INHIBITOR 9-HSA DOWNREGULATES CYCLIN D1 EXPRESSION AND ALTERS ITS FUNCTIONS 141
9-HYDROXYSTEARIC ACID INTERFERES WITH EGF SIGNALLING IN A HUMAN COLON ADENOCARCINOMA 141
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 141
Identification of a new bisindolinone arresting IGROV1 cells proliferation 140
Substituted (E)-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones as antitumor agents: SARs and study of the mechanism of action 139
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 138
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization 137
New substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity 136
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 136
Coenzyme q depletion reshapes mcf-7 cells metabolism 136
A novel nanomicellar combination of fenretinide and lenalidomide shows marked antitumor activity in a neuroblastoma xenograft model 134
Structural changes in a protein fragment from abalone shell during calcium carbonate precipitation 134
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 133
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents 132
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, citotoxic activity, and study of the mechanism of action. 131
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 131
Effect of sugars on Chlamydia trachomatis infectivity 131
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 130
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 128
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 128
CYTOTOXICITY EVALUATION OF A POLYAMINE-QUINONE LIBRARY CONJUGATES IN HUMAN COLON CARCINOMA CELLS 128
Parallel synthesis and cytotoxicity evaluation of a polyamine-quinone conjugates library 128
CYTOSTATIC AND CYTOTOXIC EFFECTS OF A NEW SYNTHESIZED GUANYLHYDRAZONE DERIVATIVES IN HUMAN LEUKEMIC CELL LINE HL-60 128
Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase 127
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites 127
THE INDOLE-DERIVATIVE 3L INTERFERES WITH ESTROGEN RECEPTOR SIGNALLING IN IGROV 1 OVARIAN CANCER CELLS 126
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 125
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 124
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 123
Sulforaphane modulates phase 2 enzyme and Nrf2 expression in cultured rat cardiomyocytes. 123
Protective effects of green tea against hypoxia-induced cytoskeletal alterations in cultured cardiomyocytes. 122
Induction of phase II enzymes by sulforaphane leads to cardioprotection 121
CYTOTOXIC EFFECTS OF 4-HYDROXYNONENAL IN HUMAN OSTEOSARCOMA CELLS 120
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 119
Enzymatic kinetic resolution of hydroxystearic acids: A combined experimental and molecular modelling investigation 119
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE 118
Hystones’ isoforms determined by HPLC-MS 117
Characterization of anti-Candida activity of vaginal lactobacilli 117
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 117
Totale 16.406
Categoria #
all - tutte 55.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.325 0 0 0 0 0 93 47 123 213 119 134 596
2021/20222.677 365 111 144 151 224 157 77 167 110 205 471 495
2022/20233.033 309 433 169 433 216 240 76 192 443 137 236 149
2023/20241.494 68 161 66 101 130 305 179 319 28 43 43 51
2024/20253.632 179 415 370 204 636 191 271 137 73 384 189 583
2025/20264.284 768 828 703 605 950 430 0 0 0 0 0 0
Totale 21.137